Geode Capital Management, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Geode Capital Management, LLC
- $1.52 Trillion
- Q3 2025
A detailed history of Geode Capital Management, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 559,243 shares of RVPH stock, worth $279,621. This represents 0.0% of its overall portfolio holdings.
Number of Shares
559,243
Previous 448,202
24.77%
Holding current value
$279,621
Previous $170,000
21.18%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RVPH
# of Institutions
50Shares Held
9.74MCall Options Held
585KPut Options Held
31.6K-
Diadema Partners LP Morristown, NJ2.51MShares$1.25 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3594KShares$296,9510.15% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA524KShares$262,0250.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...